Financial News USA - Press Release - 1002638
AMGN
is a relatively low priced stock given that it has cancer killing drugs on the fast track. I always feel a little uneasy around bio-tech, I feel that I understand semi-conductors better than bio-tech. However, bio-tech saves lives and makes money; a great combination for investors.
BUY THE BULL!
Friday, August 05, 2005
AMGN CANCER KILLER!
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment